Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Non Operating Income (2023 - 2025)

Xenetic Biosciences' Non Operating Income history spans 7 years, with the latest figure at $43951.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 81.88% year-over-year to $43951.0; the TTM value through Dec 2025 reached $88707.0, down 72.05%, while the annual FY2025 figure was $153722.0, 37.04% down from the prior year.
  • Non Operating Income reached $43951.0 in Q4 2025 per XBIO's latest filing, up from $4011.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $242618.0 in Q4 2024 to a low of -$271596.0 in Q4 2023.
  • Average Non Operating Income over 3 years is $28307.8, with a median of $21639.5 recorded in 2025.
  • Peak YoY movement for Non Operating Income: plummeted 100.01% in 2024, then surged 7133.33% in 2025.
  • A 3-year view of Non Operating Income shows it stood at -$271596.0 in 2023, then skyrocketed by 189.33% to $242618.0 in 2024, then tumbled by 81.88% to $43951.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Non Operating Income are $43951.0 (Q4 2025), $4011.0 (Q3 2025), and $1477.0 (Q2 2025).